Featured Research Areas
Lab News
San Antonio Partnership for Precision Therapeutics fuels COVID-19 research.
The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP
San Antonio Partnership for Precision Therapeutics fuels COVID-19 research.
The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP